/b/veterinary-nursing-news/posts/147497 Boehringer Ingelheim Vetmedica has launched Semintra, a new liquid treatment for cats with chronic kidney disease (CKD). The active ingredient in Semintra is telmisartan, the first angiotensin receptor blocker to be licensed in veterinary medicineen-USTelligent Community 10